BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2000
View Archived Issues
Corixa's leishmaniasis vaccine program receives additional funding
Read More
Neurocrine Biosciences reports results of phase II trial with NBI-5788 in MS
Read More
Serotonergic receptor ligands under study at Cerebrus for obesity and other disorders
Read More
New LHRH antagonists in the Abbott pipeline
Read More
New compounds from Japanese lab inhibit Th2-type cytokine production
Read More
Forbes Medi-Tech initiates phase II trial for CardioRex
Read More
Patent claim allowance for LCG-MAb received by Cytoclonal
Read More
Updated results from G-3139 clinical trial demonstrate durable response and survival
Read More
Health Canada approves Rituxan for treatment of NHL
Read More
Fuji Chemical prepares new peptides for the treatment of pain
Read More
AstraZeneca develops new class of MMP inhibitors with selectivity for MMP-13, MMP-9
Read More
Aminoalcohol-based beta3-agonists claimed by Fujisawa for incontinence, pollakiuria
Read More
Recent patent covers Merck's new tyrosine kinase inhibitors
Read More
Biological effects of SU-9516, a cdk inhibitor, studied in human colon cancer cells
Read More
Novel tumor-targeting approach taken by McGill scientists using chimeric molecules
Read More
Full human genome is sequenced for the first time
Read More
NewBiotics completes private placement and prepares to advance study of lead product
Read More
Nonsecosteroidal, nonhypercalcemic VDR agonist with antitumor activity designed at Ligand
Read More
Positive preclinical data obtained for naked DNA prostate cancer vaccine
Read More
NitroMed searches for new, more effective treatments for MED: nitrated PGE1 analogues
Read More
More stable antimalarial aminoquinolines sought by Tulane investigators
Read More
Teva completes acquisition of Novopharm
Read More
Fujisawa's COX-2 inhibitor FK-3311 protects against I/R injury in lung transplantation
Read More
Alexion to commence phase Ib pilot study of 5G1.1 in pemphigoid patients
Read More
Catechin consumption protects against atherosclerosis in mouse model
Read More
Synthetic factor Xa inhibitor better than LMWH in rat model of DIC
Read More
Boston Life Sciences initiates phase II testing of Altropane in ADHD diagnosis
Read More